Moderna
MRNA
#1137
Rank
NZ$34.52 B
Marketcap
NZ$87.05
Share price
-1.18%
Change (1 day)
75.45%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: NZ$34.52 Billion

As of April 2026 Moderna has a market cap of NZ$34.52 Billion. This makes Moderna the world's 1137th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$34.52 B64.01%
2025NZ$21.04 B-23.13%
2024NZ$27.38 B-54.33%
2023NZ$59.95 B-44.83%
2022NZ$108.68 B-27.91%
2021NZ$150.76 B163.14%
2020NZ$57.29 B486.18%
2019NZ$9.77 B30.58%
2018NZ$7.48 B

End of Day market cap according to different sources

On Mar 31st, 2026 the market cap of Moderna was reported to be:

NZ$34.93 Billion
by Nasdaq info icon info icon
NZ$34.93 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.025 T 2,870.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$519.71 B 1,405.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$519.09 B 1,403.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
NZ$0.97 B-97.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
NZ$5.16 B-85.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
NZ$1.44 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$76.08 B 120.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$15.64 B-54.68%๐Ÿ‡บ๐Ÿ‡ธ USA